Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > etoposide (VP-16)

Etoposide (VP-16) : Abbott Labs : Chemotherapeutic agent

Etoposide for SCLC
Etoposide for NSCLC
Etoposide Side Effects

Etoposide for SCLC

Etoposide for SCLC - Recent MEDLINE Abstracts (PubMed)

Etoposide in SCLC Clinical Trials (ClinicalTrials.gov)



Etoposide for NSCLC

Etoposide for NSCLC - Recent MEDLINE Abstracts (PubMed)

Paclitaxel-Cisplatin Better Than Etoposide-Cisplatin for Advanced NSCLC (PubMed)
Abstract of a study reported in the February 2000 issue of the Journal of Clinical Oncology that showed, with regard to survival, that the combination of paclitaxel-cisplatin is superior to etoposide-cisplatin in patients with stage IIIB and stage IV NSCLC. [2/00]

Etoposide in NSCLC Clinical Trials (ClinicalTrials.gov)



Side Effects

Etoposide (CancerBACUP)
Factsheet describes etoposide (also known as VP-16), how it is given and some of its possible side effects. [11/02]




 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 18-Feb-2009
Karen Parles, MLS Editor